GBA1 and Parkinson disease: Mounting evidence implicates neuroinflammation in PD pathogenesis, with elevated immune markers reported in the plasma (Miliukhina et al. 2020) and brain tissue (Mullin et al. 2021) isolated from GBA1-PD patients.